You are here

  • Home
  • Archive
  • Volume 10, Issue 2
  • Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches

Article metrics

Article menu
Basic tumor immunology
Original research
Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches

 

Online download statistics by month:

Online download statistics by month: February 2022 to September 2025

AbstractFullPdf
Feb 2022969615
Mar 2022926955247
Apr 2022210227108
May 202219922093
Jun 202214314651
Jul 202216416841
Aug 202217218048
Sep 202217418589
Oct 202217618584
Nov 202213914146
Dec 202210911234
Jan 2023848733
Feb 202311211231
Mar 2023858738
Apr 2023565621
May 2023676924
Jun 2023494914
Jul 2023788027
Aug 2023767744
Sep 2023656725
Oct 2023606127
Nov 2023727230
Dec 2023666629
Jan 2024444526
Feb 2024595932
Mar 2024848472
Apr 2024565835
May 2024636423
Jun 2024555633
Jul 2024646641
Aug 2024393522
Sep 20245354374
Oct 2024626339
Nov 2024575931
Dec 202411712070
Jan 2025939445
Feb 2025757744
Mar 2025888954
Apr 2025969865
May 2025575734
Jun 2025394026
Jul 2025110
Sep 2025110
Total458147182265